ArticleDiabetes2025

Activation of the HPA Axis Does Not Explain Nonresponsiveness to GLP-1R Agonist Treatment in Individuals With Type 2 Diabetes.

Sevilay Tokgöz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.